Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
British Journal of Clinical Pharmacology|May 7, 2020
Usefulness of therapeutic drug monitoring of rilpivirine and its relationship with virologic response and resistance in a cohort of naive and pretreated HIV-infected patientsNadège Néant, Minh Patrick Lê, Naïm Bouazza, et al.
British Journal of Clinical Pharmacology|March 18, 2004
Therapeutic drug monitoring of lopinavir/ritonavir given alone or with a non-nucleoside reverse transcriptase inhibitorCaroline Solas, Isabelle Poizot-Martin, Marie-Pierre Drogoul, et al.
British Journal of Clinical Pharmacology|May 23, 2007
Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patientsCaroline Solas, Nicolas Simon, Marie-Pierre Drogoul, et al.
Nature Communications|October 3, 2018
Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategiesVincent Madelain, Sylvain Baize, Frédéric Jacquot, et al.
The Journal of Antimicrobial Chemotherapy|June 22, 2019
Concentration-response model of rilpivirine in a cohort of HIV-1-infected naive and pre-treated patientsNadège Néant, Caroline Solas, Naïm Bouazza, et al.
AIDS (London, England)|May 6, 2016
Estimated glomerular filtration rate but not solute carrier polymorphisms influences anemia in HIV-hepatitis C virus coinfected patients treated with boceprevir or telaprevir-based therapyFarid Kheloufi, Eric Bellissant, Laurent Cotte, et al.
Antiviral Therapy|September 2, 2016
ITPA deficiency and ribavirin level are still predictive of anaemia in HCV-HIV-coinfected patients receiving ribavirin combined with a first-generation DAA (ANRS HC27 study)Farid Kheloufi, Isabelle Poizot-Martin, Rodolphe Garraffo, et al.
Toxicology Letters|January 31, 2006
Identification by single-strand conformational polymorphism analysis of known and new mutations of the CYP3A5 gene in a French populationSylvie Quaranta, Dany Chevalier, Véronique Bourgarel-Rey, et al.
Scientific Reports|June 5, 2017
A simple and rapid LC-MS/MS method for therapeutic drug monitoring of cetuximab: a GPCO-UNICANCER proof of concept study in head-and-neck cancer patientsFrançois Becher, Joseph Ciccolini, Diane-Charlotte Imbs, et al.
Therapeutic Drug Monitoring|October 14, 2006
A rapid and inexpensive method for anticipating severe toxicity to fluorouracil and fluorouracil-based chemotherapyJoseph Ciccolini, Cédric Mercier, Alexandre Evrard, et al.
Pageof 9